Literature DB >> 26417265

Cytochrome P450 enzyme mediated herbal drug interactions (Part 1).

Sompon Wanwimolruk1, Virapong Prachayasittikul2.   

Abstract

It is well recognized that herbal supplements or herbal medicines are now commonly used. As many patients taking prescription medications are concomitantly using herbal supplements, there is considerable risk for adverse herbal drug interactions. Such interactions can enhance the risk for an individual patient, especially with regard to drugs with a narrow therapeutic index such as warfarin, cyclosporine A and digoxin. Herbal drug interactions can alter pharmacokinetic or/and pharmacodynamic properties of administered drugs. The most common pharmacokinetic interactions usually involve either the inhibition or induction of the metabolism of drugs catalyzed by the important enzymes, cytochrome P450 (CYP). The aim of the present article is to provide an updated review of clinically relevant metabolic CYP-mediated drug interactions between selected herbal supplements and prescription drugs. The commonly used herbal supplements selected include Echinacea, Ginkgo biloba, garlic, St. John's wort, goldenseal, and milk thistle. To date, several significant herbal drug interactions have their origins in the alteration of CYP enzyme activity by various phytochemicals. Numerous herbal drug interactions have been reported. Although the significance of many interactions is uncertain but several interactions, especially those with St. John's wort, may have critical clinical consequences. St. John's wort is a source of hyperforin, an active ingredient that has a strong affinity for the pregnane xenobiotic receptor (PXR). As a PXR ligand, hyperforin promotes expression of CYP3A4 enzymes in the small intestine and liver. This in turn causes induction of CYP3A4 and can reduce the oral bioavailability of many drugs making them less effective. The available evidence indicates that, at commonly recommended doses, other selected herbs including Echinacea, Ginkgo biloba, garlic, goldenseal and milk thistle do not act as potent or moderate inhibitors or inducers of CYP enzymes. A good knowledge of the mechanisms of herbal drug interactions is necessary for assessing and minimizing clinical risks. These processes help prediction of interactions between herbal supplements and prescription drugs. Healthcare professionals should remain vigilant for potential interactions between herbal supplements/medicines and prescription drugs, especially for drugs with a narrow therapeutic index are used.

Entities:  

Keywords:  CYP; botanical supplements; dietary supplements; drug interactions; herbal drug interactions; herbal medicines

Year:  2014        PMID: 26417265      PMCID: PMC4463967     

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.068


  192 in total

1.  Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis.

Authors:  A N Nafziger; J S Bertino
Journal:  Clin Pharmacol Ther       Date:  2007-02-28       Impact factor: 6.875

Review 2.  Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes.

Authors:  F P Guengerich; T Shimada
Journal:  Chem Res Toxicol       Date:  1991 Jul-Aug       Impact factor: 3.739

Review 3.  Role of genetics and drug metabolism in human cancer risk.

Authors:  D W Nebert
Journal:  Mutat Res       Date:  1991-04       Impact factor: 2.433

4.  The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone.

Authors:  G D Loizou; J Cocker
Journal:  Hum Exp Toxicol       Date:  2001-07       Impact factor: 2.903

5.  Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding.

Authors:  Patricia A Murphy; Steven E Kern; Frank Z Stanczyk; Carolyn L Westhoff
Journal:  Contraception       Date:  2005-06       Impact factor: 3.375

6.  Methadone maintenance treatment and St. John's Wort - a case report.

Authors:  D Eich-Höchli; R Oppliger; K Powell Golay; P Baumann; C B Eap
Journal:  Pharmacopsychiatry       Date:  2003-01       Impact factor: 5.788

Review 7.  Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.

Authors:  Shu-Feng Zhou; Bo Wang; Li-Ping Yang; Jun-Ping Liu
Journal:  Drug Metab Rev       Date:  2010-05       Impact factor: 4.518

Review 8.  Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.

Authors:  Ann K Wittkowsky
Journal:  Semin Vasc Med       Date:  2003-08

9.  An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.

Authors:  Amy S Etheridge; Sherry R Black; Purvi R Patel; James So; James M Mathews
Journal:  Planta Med       Date:  2007-07-05       Impact factor: 3.352

10.  Chemical comparison of goldenseal (Hydrastis canadensis L.) root powder from three commercial suppliers.

Authors:  Holly A Weber; Matthew K Zart; Andrew E Hodges; H Michael Molloy; Brandon M O'Brien; Leslie A Moody; Alice P Clark; Roger K Harris; J Diane Overstreet; Cynthia S Smith
Journal:  J Agric Food Chem       Date:  2003-12-03       Impact factor: 5.279

View more
  22 in total

1.  Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury.

Authors:  Robert A Roth; Omar Kana; David Filipovic; Patricia E Ganey
Journal:  Expert Opin Drug Metab Toxicol       Date:  2022-08-24       Impact factor: 4.936

Review 2.  Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond.

Authors:  Ruizhi Gu; Alina Liang; Grace Liao; Isabelle To; Amina Shehu; Xiaochao Ma
Journal:  Drug Metab Dispos       Date:  2022-02-27       Impact factor: 3.579

3.  Evaluation of the impact of Flos Daturae on rat hepatic cytochrome P450 enzymes by cocktail probe drugs.

Authors:  Peiwu Geng; Shuanghu Wang; Chunjie Wang; Jianmiao Chen; Lijing Zhang; Suping Yang; Congcong Wen; Yunfang Zhou; Meiling Zhang
Journal:  Int J Clin Exp Med       Date:  2015-12-15

4.  A Systematic Review of Drug Metabolism Studies of Plants With Anticancer Properties: Approaches Applied and Limitations.

Authors:  Artitaya Thiengsusuk; Kanyarat Boonprasert; Kesara Na-Bangchang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-04       Impact factor: 2.441

5.  Effects of Complementary and Alternative Medicine on Chemotherapy Delivery in Thai Patients.

Authors:  Chawanya Rabiltossaporn; Ploytuangporn Wongchanapai; Nattaya Poovoravan; Piyada Sitthideatphaiboon; Virote Sriuranpong; Suebpong Tanasanvimon
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01

6.  Use of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by Stilbenes.

Authors:  Loai Basheer; Keren Schultz; Merav Fichman; Zohar Kerem
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

Review 7.  Interactions between CYP3A4 and Dietary Polyphenols.

Authors:  Loai Basheer; Zohar Kerem
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

8.  Characterization of the mechanism of drug-drug interactions from PubMed using MeSH terms.

Authors:  Yin Lu; Bryan Figler; Hong Huang; Yi-Cheng Tu; Ju Wang; Feng Cheng
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

Review 9.  Cytochrome P450 enzyme mediated herbal drug interactions (Part 2).

Authors:  Sompon Wanwimolruk; Kamonrat Phopin; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2014-08-20       Impact factor: 4.068

10.  Daikenchuto (TU-100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawal.

Authors:  Kentaro Nobutani; Jun Miyoshi; Mark W Musch; Mitsue Nishiyama; Junko Watanabe; Atsushi Kaneko; Masahiro Yamamoto; Masaru Yoshida; Toru Kono; Hyunyoung Jeong; Eugene B Chang
Journal:  Pharmacol Res Perspect       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.